Alpa Laboratories Limited

BSE:532878 Stock Report

Market Cap: ₹2.6b

Alpa Laboratories Past Earnings Performance

Past criteria checks 2/6

Alpa Laboratories has been growing earnings at an average annual rate of 32.4%, while the Pharmaceuticals industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 4.5% per year. Alpa Laboratories's return on equity is 12.6%, and it has net margins of 21.4%.

Key information

32.4%

Earnings growth rate

32.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate4.5%
Return on equity12.6%
Net Margin21.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Alpa Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532878 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249732081610
30 Jun 241,0871621330
31 Mar 241,0871681560
31 Dec 231,1481781350
30 Sep 231,1481851320
30 Jun 231,0541301240
31 Mar 239301261250
31 Dec 221,007451210
30 Sep 221,012481210
30 Jun 221,1391031180
31 Mar 221,1231411230
31 Dec 211,1211561160
30 Sep 211,1591391250
30 Jun 211,1281051210
31 Mar 21976721200
31 Dec 20907691260
30 Sep 20817581180
30 Jun 20821391150
31 Mar 20860191220
31 Dec 1986991290
30 Sep 1988861280
30 Jun 19817111270
31 Mar 19780101260
31 Mar 18628281060
31 Mar 1763525890
31 Mar 1653668990
31 Mar 15574-14880
31 Dec 14618-191360
30 Sep 14627-461380
30 Jun 14573-601380
31 Mar 14567-521350

Quality Earnings: 532878 has a high level of non-cash earnings.

Growing Profit Margin: 532878's current net profit margins (21.4%) are higher than last year (16.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532878's earnings have grown significantly by 32.4% per year over the past 5 years.

Accelerating Growth: 532878's earnings growth over the past year (12.6%) is below its 5-year average (32.4% per year).

Earnings vs Industry: 532878 earnings growth over the past year (12.6%) did not outperform the Pharmaceuticals industry 20.6%.

Return on Equity

High ROE: 532878's Return on Equity (12.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 11:21
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alpa Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research